University of Queensland
scientists say clinical trials for a
new dengue fever treatment could
start within 12 months, after they
identified similarities in how the
body reacts to dengue virus and
bacterial infections.
The dengue virus NS1 protein acts
as a toxin in the body in a similar
manner to the way bacterial cell
wall products lead to septic shock
in bacterial infections - meaning
existing drugs could possibly be repurposed
to treat dengue fever.The above article was sent to subscribers in Pharmacy Daily's issue from 11 Sep 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 11 Sep 15
PEAK pharmacy bodies are calling on the Australian Government to extend the new Commonwealth Prac Payment to pharmacy students, citing the challenges of “placement poverty” in unpaid practical placements.
AFT Pharmaceuticals is set to develop a topical treatment for keloid and hypertrophic scarring in partnership with NZ’s Massey Ventures, the commercialisation arm of Massey University, and the Gillies McIndoe Research Institute.
THE Pharmaceutical Society of Australia (PSA) awarded Brooke Shelly the prestigious 2024 PSA MIMS Credentialed Pharmacist of the Year award last Fri at the Credentialed Pharmacist Conference (CPC24) (PD breaking news).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.